Iovance Biotherapeutics Inc
NASDAQ:IOVA

Watchlist Manager
Iovance Biotherapeutics Inc Logo
Iovance Biotherapeutics Inc
NASDAQ:IOVA
Watchlist
Price: 2.26 USD -2.16% Market Closed
Market Cap: 754.7m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+386%
Revenue
Forecast
+65%
Operating Income
Forecast
+35%
Net Income
Forecast
N/A

Wall Street
Price Targets

IOVA Price Targets Summary
Iovance Biotherapeutics Inc

Wall Street analysts forecast IOVA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IOVA is 10.99 USD with a low forecast of 2.02 USD and a high forecast of 26.25 USD.

IOVA Lowest Forecast
Wall Street Target
2.02 USD
11% Downside
IOVA Average Forecast
Wall Street Target
10.99 USD
386% Upside
IOVA Highest Forecast
Wall Street Target
26.25 USD
1 062% Upside
Lowest
Price Target
2.02 USD
11% Downside
Average
Price Target
10.99 USD
386% Upside
Highest
Price Target
26.25 USD
1 062% Upside
Iovance Biotherapeutics Inc Competitors:
Price Targets
BEAM
Beam Therapeutics Inc
165% Upside
M
GLUE
Monte Rosa Therapeutics Inc
235% Upside
4974
Takara Bio Inc
63% Upside
1530
3SBio Inc
9% Downside
BEAM
Beam Therapeutics Inc
165% Upside
M
GLUE
Monte Rosa Therapeutics Inc
235% Upside
4974
Takara Bio Inc
63% Upside
1530
3SBio Inc
9% Downside
P
PRME
Prime Medicine Inc
414% Upside
LYEL
Lyell Immunopharma Inc
68% Upside
BOLT
Bolt Biotherapeutics Inc
555% Upside
VRTX
Vertex Pharmaceuticals Inc
13% Upside

Revenue
Forecast

Revenue Estimate
Iovance Biotherapeutics Inc

The compound annual growth rate of Iovance Biotherapeutics Inc's revenue for the next 3 years is 65%.

N/A
Past Growth
65%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Iovance Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Iovance Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-65%
Average Miss
What are analyst estimates?

See Also

Summary
IOVA intrinsic value, competitors valuation, and company profile.
DCF Valuation
IOVA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IOVA stock valuation using valuation multiples.
Wall Street Estimates
IOVA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IOVA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IOVA's stock price target?
Price Target
10.99 USD

According to Wall Street analysts, the average 1-year price target for IOVA is 10.99 USD with a low forecast of 2.02 USD and a high forecast of 26.25 USD.

What is Iovance Biotherapeutics Inc's Revenue forecast?
Projected CAGR
65%

The compound annual growth rate of Iovance Biotherapeutics Inc's revenue for the next 3 years is 65%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.